Coming of Age — The Chemoprevention of Cancer
- 20 September 1990
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 323 (12), 825-827
- https://doi.org/10.1056/nejm199009203231210
Abstract
With the aging of the population and the continued fall in rates of mortality from cardiovascular diseases, cancer will emerge soon after the year 2000 with the dubious distinction of being the leading cause of death in the United States. Unfortunately, dramatic therapeutic successes in the treatment of cancer plateaued in the mid-1970s, and advances since have been incremental. Whether the remarkable progress in our understanding of the biologic and genetic underpinnings of normal and transformed cellular growth in the past 15 years will be translated into substantial therapeutic benefit remains to be demonstrated. Alternatives to therapy of late disease . . .Keywords
This publication has 5 references indexed in Scilit:
- Prevention of Second Primary Tumors with Isotretinoin in Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 1990
- A Clinical Trial of Beta Carotene to Prevent Basal-Cell and Squamous-Cell Cancers of the SkinNew England Journal of Medicine, 1990
- Biomarkers as Intermediate End Points in Chemoprevention TrialsJNCI Journal of the National Cancer Institute, 1990
- Diet and Cancer – An OverviewNew England Journal of Medicine, 1984
- Can dietary beta-carotene materially reduce human cancer rates?Nature, 1981